Scientists from the Victorian government's department of primary industries in Melbourne, Australia, have isolated a compound from wallaby milk with significant antimicrobial properties, reported the UK's Sunday Times.
The novel protein, AGG01, was found to be a hundred times more effective against Escherichia coli than the most potent forms of penicillin, and killed a host of other pathogens including candida and a strain of bacteria related to methicillin-resistant Streptococcus aureus.
Wallabies, which are a smaller relative of the kangaroo indiginous to Australia, utilize the agent to protect new-born wallabies from infection while they grow in their mother's pouch.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze